Renkonen-Sinisalo Laura, Seppälä Toni T, Järvinen Heikki J, Mecklin Jukka-Pekka
1 Department of Gastrointestinal Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland 2 Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland 3 Department of Education and Science, Central Finland Health Care District, Jyväskylä Finland and University of Eastern Finland, Finland.
Dis Colon Rectum. 2017 Aug;60(8):792-799. doi: 10.1097/DCR.0000000000000802.
The risk of metachronous colorectal cancer is high after surgical resection for first colon cancer in Lynch syndrome.
This study aimed to examine whether extended surgery decreases the risk of subsequent colorectal cancer and improves long-term survival.
This was a retrospective study.
Data were collected from a nationwide registry.
Two hundred forty-two Lynch syndrome pathogenic variant carriers who underwent surgery for a first colon cancer from 1984 to 2009 were included.
Patients underwent standard segmental colectomy (n = 144) or extended colectomy (n = 98) for colon cancer. Patients were followed a median of 14.6 up to 25 years.
Risk of subsequent colorectal cancer in either group, overall and disease-specific survival, and operative mortality were the primary outcomes measured.
Subtotal colectomy decreased the risk of subsequent colorectal cancer (HR, 0.20; 95% CI, 0.08-0.52; p = 0.001), compared with segmental resection. Subsequent colorectal cancer decreased in MLH1 carriers. The MSH2 carriers showed no statistical difference, possibly because of their small number. Disease-specific and overall survival within 25 years did not differ between the standard and extended surgeries (82.7% vs 87.2%, p = 0.76 and 47.2% vs 41.4%, p = 0.83). The cumulative risk of subsequent colorectal cancer was 20% in 10 years and 47% within 25 years after standard resection and 4% and 9% after extended surgery. The cumulative risk of metachronous colorectal cancer was 7% within 25 years after subtotal colectomy with ileosigmoidal anastomosis. One patient died of postoperative septicemia within 30 days after segmental colectomy.
Data on surgical procedures were primarily collected retrospectively.
Lynch syndrome pathogenic variant carriers may undergo subtotal colectomy to manage first colon cancer and avoid repetitive abdominal surgery and to reduce the remaining bowel to facilitate easier endoscopic surveillance. It provides no survival benefit, compared with segmental colon resection. See Video Abstract at http://links.lww.com/DCR/A319.
林奇综合征患者首次结肠癌手术后发生异时性结直肠癌的风险很高。
本研究旨在探讨扩大手术是否能降低后续结直肠癌的风险并提高长期生存率。
这是一项回顾性研究。
数据来自全国性登记处。
纳入了1984年至2009年因首次结肠癌接受手术的242名林奇综合征致病基因变异携带者。
患者因结肠癌接受标准节段性结肠切除术(n = 144)或扩大结肠切除术(n = 98)。患者的中位随访时间为14.6年,最长达25年。
两组中后续结直肠癌的风险、总生存率和疾病特异性生存率以及手术死亡率是主要测量结果。
与节段性切除术相比,次全结肠切除术降低了后续结直肠癌的风险(HR,0.20;95%CI,0.08 - 0.52;p = 0.001)。MLH1基因携带者的后续结直肠癌风险降低。MSH2基因携带者无统计学差异,可能是因为其数量较少。标准手术和扩大手术在25年内的疾病特异性生存率和总生存率无差异(82.7%对87.2%,p = 0.76;47.2%对41.4%,p = 0.83)。标准切除术后10年内后续结直肠癌的累积风险为20%,25年内为47%;扩大手术后分别为4%和9%。回肠乙状结肠吻合次全结肠切除术后25年内异时性结直肠癌的累积风险为7%。1名患者在节段性结肠切除术后30天内死于术后败血症。
手术程序数据主要是回顾性收集的。
林奇综合征致病基因变异携带者可接受次全结肠切除术来治疗首次结肠癌,避免重复腹部手术,并减少剩余肠段以利于更简便的内镜监测。与节段性结肠切除术相比,它并无生存获益。见视频摘要:http://links.lww.com/DCR/A319 。